Angiogenesis , Metastasis , and the Cellular Microenvironment Relaxin Enhances the Collagenolytic Activity and In Vitro Invasiveness by Upregulating Matrix Metalloproteinases in Human Thyroid Carcinoma Cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteolytic activation of heparin‐binding EGF‐like growth factor by membrane‐type matrix metalloproteinase‐1 in ovarian carcinoma cells

  2011cited by this paper
• Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer

  2010cited by this paper
• Matrix metalloproteinases: regulators of the tumor microenvironment.

  2010cited by this paper
• Membrane-type MMPs are indispensable for placental labyrinth formation and development.

  2010cited by this paper
• Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.

  2010cited by this paper
• INSL3 has tumor‐promoting activity in thyroid cancer

  2010cited by this paper
• Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.

  2010cited by this paper
• Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats

  2010cited by this paper
• Relaxin Enhances S100A4 and Promotes Growth of Human Thyroid Carcinoma Cell Xenografts

  2010cited by this paper
• Investigation of the local expression of the relaxin system in canine mammary tumours.

  2009cited by this paper
• Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

  2009cited by this paper
• Induction of MMP-1 (collagenase-1) by relaxin in fibrocartilaginous cells requires both the AP-1 and PEA-3 promoter sites.

  2009cited by this paper
• Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions

  2009cited by this paper
• Lysosomal Acid Hydrolases of the Cathepsin Family Are Novel Targets of INSL3 in Human Thyroid Carcinoma Cells

  2009cited by this paper
• Relaxin stimulates MMP-2 and alpha-smooth muscle actin expression by human periodontal ligament cells.

  2008cited by this paper
• Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase.

  2008cited by this paper
• Expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinase 2 (TIMP-2) in medullary thyroid carcinoma: prognostic implications.

  2008cited by this paper
• Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells

  2008cited by this paper
• Relaxin physiology in the female reproductive tract during pregnancy.

  2007cited by this paper
• MT1-MMP Controls Tumor-induced Angiogenesis through the Release of Semaphorin 4D*

  2007cited by this paper
• Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness.

  2007cited by this paper
• Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies.

  2007cited by this paper
• Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.

  2006cited by this paper
• H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis

  2006cited by this paper
• Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model.

  2006cited by this paper
• The role of relaxin in endometrial cancer

  2006cited by this paper
• Relaxin Modulates Fibroblast Function, Collagen Production, and Matrix Metalloproteinase‐2 Expression by Cardiac Fibroblasts

  2005influential reference
• The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.

  2005cited by this paper
• Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease.

  2005influential reference
• Human Medullary Thyroid Carcinoma: A Source and Potential Target for Relaxin‐Like Hormones

  2005cited by this paper
• Inhibition of lymphangiogenesis‐related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270

  2004cited by this paper
• Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo.

  2004cited by this paper
• Matrix metalloproteinases in thyroid cancer.

  2004cited by this paper
• Elevated Concentrations of Serum Relaxin are Associated with Metastatic Disease in Breast Cancer Patients

  2004cited by this paper
• Distinct Roles for the Catalytic and Hemopexin Domains of Membrane Type 1-Matrix Metalloproteinase in Substrate Degradation and Cell Migration*

  2004cited by this paper
• Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.

  2004cited by this paper
• Emerging role of relaxin in renal and cardiovascular function.

  2004cited by this paper
• Relaxin regulates fibrillin 2, but not fibrillin 1, mRNA and protein expression by human dermal fibroblasts and murine fetal skin.

  2003cited by this paper
• Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo.

  2003cited by this paper
• Relaxin‐like peptides in cancer

  2003cited by this paper
• A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

  2003cited by this paper
• Adenovirus-mediated expression of human prorelaxin promotes the invasive potential of canine mammary cancer cells.

  2003cited by this paper
• Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.

  2003cited by this paper
• Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig.

  2002cited by this paper
• MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression

  2002cited by this paper
• Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.

  2002influential reference
• Matrix metalloproteinases in skin pathology (Review).

  2001cited by this paper
• Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration

  2001cited by this paper
• Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.

  2001cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cited by this paper
• Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

  2001cited by this paper
• Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas

  2001cited by this paper
• MMP-2 colocalizes with caveolae on the surface of endothelial cells.

  2001cited by this paper
• EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.

  2000cited by this paper
• Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3

  2000cited by this paper
• Collagen Studies in Late Pregnant Relaxin Null Mice1

  2000cited by this paper
• Influence of proliferation, differentiation and dedifferentiation factors on the expression of the lysosomal cysteine proteinase cathepsin L (CL) in thyroid cancer cell lines.

  2000cited by this paper
• Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor.

  2000cited by this paper
• Regulation of matrix metalloproteinase expression in tumor invasion

  1999cited by this paper
• Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.

  1999cited by this paper
• MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.

  1999cited by this paper
• Targeted induction of collagenase and stromelysin by relaxin in unprimed and beta-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes.

  1998cited by this paper
• Localisation of a novel adhesion blocking epitope on the human beta 1 integrin chain.

  1998cited by this paper
• mRNA Levels of Membrane-type 1 Matrix Metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their Inhibitors TIMP-2 and TIMP-3 in Normal Thyrocytes and Thyroid Carcinoma Cell Lines

  1998cited by this paper
• Regulation of urokinase- and tissue-type plasminogen activator by relaxin in the uterus and cervix of the prepubertal gilt.

  1998cited by this paper
• Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matrix Metalloproteinase-1 and Tissue Matrix Metalloproteinase Inhibitor-1 Messenger-RNA and Protein

  1997cited by this paper
• An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1).

  1997cited by this paper
• An autocrine/paracrine role of human decidual relaxin. I. Interstitial collagenase (matrix metalloproteinase-1) and tissue plasminogen activator.

  1997cited by this paper
• Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

  1996cited by this paper
• Stromal Fibroblasts Adjacent to Invasive Thyroid Tumors: Expression of Gelatinase A But Not Stromelysin 3 mRNA

  1996cited by this paper
• Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase

  1995cited by this paper
• Human relaxins in normal, benign and neoplastic breast tissue.

  1994cited by this paper
• Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis.

  1993cited by this paper
• RELAXIN‐INDUCED ELEVATIONS OF CATHEPSIN B AND DIPEPTIDYL PEPTIDASE I IN THE MOUSE PUBIC SYMPHYSIS, WITH LOCALIZATION BY FLUORESCENCE ENZYME HISTOCHEMISTRY *

  1982cited by this paper
• The FASEB Journal • Research Communication Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth

  year unknowncited by this paper
• Tumorigenesis and Neoplastic Progression Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells

  year unknowninfluential reference
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Relaxin Increases Secretion of Matrix Metalloproteinase- 2 and Matrix Metalloproteinase-9 during Uterine and Cervical Growth and Remodeling in the Pig

  year unknowncited by this paper

• The dual and multifaceted role of relaxin-2 in cancer

  2023cites this paper
• Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma—A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study

  2023cites this paper
• Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer

  2022cites this paper
• TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer

  2021cites this paper
• Differential Expression of the Androgen Receptor, Splice Variants and Relaxin 2 in Renal Cancer

  2021cites this paper
• Novel CTRP8‐RXFP1‐JAK3‐STAT3 axis promotes Cdc42‐dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells

  2021cites this paper
• BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis

  2020cites this paper
• CRLF1–MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis

  2020cites this paper
• Emerging roles for the relaxin/RXFP1 system in cancer therapy.

  2019cites this paper
• The Role of MMP8 in Cancer: A Systematic Review

  2019cites this paper
• Structural commonality of C1q TNF‐related proteins and their potential to activate relaxin/insulin‐like family peptide receptor 1 signalling pathways in cancer cells

  2017cites this paper
• Relaxin and insulin‐like peptide 3 in the musculoskeletal system: from bench to bedside

  2016cites this paper
• Relaxin-2 Expression in Oral Squamous Cell Carcinoma

  2016cites this paper
• Targeting the relaxin hormonal pathway in prostate cancer

  2015cites this paper
• RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance

  2015cites this paper
• Relaxin-2 expression in temporal bone carcinoma

  2015cites this paper
• RXFP1 is Targeted by Complement C1q Tumor Necrosis Factor-Related Factor 8 in Brain Cancer

  2015cites this paper
• Presence of relaxin‐2, oxytocin and their receptors in uterosacral ligaments of pre‐menopausal patients with and without pelvic organ prolapse

  2014influential citation
• Vandetanib-induced inhibition of neuroblastoma cell migration and invasion is associated with downregulation of the SDF-1/CXCR4 axis and matrix metalloproteinase 14.

  2014cites this paper
• Relaxin promotes in vitro tumour growth, invasion and angiogenesis of human Saos-2 osteosarcoma cells by AKT/VEGF pathway.

  2013cites this paper
• C1q‐tumour necrosis factor‐related protein 8 (CTRP8) is a novel interaction partner of relaxin receptor RXFP1 in human brain cancer cells

  2013cites this paper
• The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.

  2012cites this paper